| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 16709 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 44266 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 113420 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 173853 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 265318 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 293961 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 360483 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 371529 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 711276 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1308933 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1378671 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1400627 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1450205 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1524373 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1603420 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1617979 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1655994 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1657671 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1718736 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1931034 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1952571 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 1998616 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 2020218 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 2181809 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 2216778 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 2237807 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 2646335 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (22:6) (docosahexaenoic acid) | 3082782 | Peak height | LGG Treated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|